VISIBLE: Women's heart disease revealed

The goal of VISIBLE is to increase the proportion of women presenting with stable angina who receive effective diagnosis and treatment for coronary microvascular disease from less than 1% to more than 80%, without increasing the risk of missed diagnosis or treatment of obstructive coronary artery disease..

  Thrust 1: Develop scalable approaches for diagnosis and monitoring of coronary microvascular disease.

. Thrust 2: Identify risk factors and evaluate prognosis of coronary microvascular disease endotypes.

  Thrust 3: Build and validate multiscale human-relevant models of the coronary microvasculature to interrogate causal mechanisms of coronary microvascular disease.

  Thrust 4: Develop treatment strategies that improve both coronary microvascular function and patient-centered outcomes.

Funding: No fixed limit 

Duration: 2 years

Research Authority due date: 2.3.26

Abstract (required) due date: 9.3.26

Full proposal due date: 24.4.26